Position in PFE
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,346,168
+$82,456 QoQ
Shares Held
55,904
+24.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,150
of 2,821 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2023CallValue
$146,720
CallShares
4,000
PutValue
$91,700
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baader Bank Aktiengesellschaft holds $38,581,797 across 9 Drug Manufacturers - General names. PFE ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,924 | $10,703,714 | |
| 2 | JNJ |
Johnson & Johnson
|
38,394 | $9,750,924 | |
| 3 | BIIB |
Biogen Inc.
|
28,568 | $6,172,402 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,582 | $5,214,787 | |
| 5 | ABBV |
AbbVie Inc.
|
10,017 | $2,520,677 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
11,970 | $1,512,289 | |
| 7 | PFE |
Pfizer Inc
This page
|
55,904 | $1,346,168 | |
| 8 | AZN |
Astrazeneca PLC
|
4,699 | $891,024 |
All Filings in PFE
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,346,168 | 55,904 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,263,712 | 45,004 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,134,792 | 45,574 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,878,258 | 73,715 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $2,062,727 | 85,096 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $1,744,836 | 68,857 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,803,509 | 67,980 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,179,355 | 75,306 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,352,357 | 48,333 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,234,875 | 44,500 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,238,854 | 77,765 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,020,484 | 60,913 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $146,720 | 4,000 | Call | Sole | 2023-08-11 | |
| 2023-06-30 | $1,752,130 | 47,768 | Shares | Sole | 2023-08-11 | |
| 2023-06-30 | $91,700 | 2,500 | Put | Sole | 2023-08-11 | |
| 2023-03-31 | $1,306,497 | 32,022 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,247,181 | 63,372 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,672,510 | 61,072 | Shares | Sole | 2023-05-04 | |
| 2022-06-30 | $3,982,163 | 75,952 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $15,318,018 | 295,886 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $17,020,572 | 288,240 | Shares | Sole | 2022-09-06 | |
| No filing history on record for this holder in this stock. | ||||||